Amaç: Sağlık çalışanlarının halkı bilgilendirmedeki etkin rolü göz önüne alındığında hemşirelik öğrencileri, tıp öğrencileri ve hemşirelerin serviks kanseri, HPV ve HPV aşıları hakkındaki bilinç düzeyinin tespit edilmesini ve bilinçlendirme ihtiyacının araştırılmasını amaçladık ve İstanbul Bilim Üniversitesi öğrencileri ve afiliye hastanelerdeki sağlık çalışanlarının HPV ve serviks kanseri hakkındaki bilgilerini değerlendirdik.
INTRODUCTION
Cervical cancer is the 9th most common cancer among women in Turkey. Every year approximately 1500 cervical cancer cases are diagnosed and nearly half of these cases die.
1 Systematic screening has been shown to decrease death rates from cervical cancer by more than 70%. 2 There are no organized mass screening programs in Turkey, but pap smear test is afforded by the government.
Human papillomavirus (HPV) has been identified as the major risk factor for cervical cancer 3 and it is the most common sexually transmitted disease (STD). 4, 5 Cofactors such as using oral contraceptives, smoking, low socioeconomic status and promiscuous sexual behavior also play a role in the etiopathogenesis. Findings in previous surveys indicate that the knowledge about HPV vaccine among the general public is low. [6] [7] [8] [9] HPV prevalence in Turkey was reported to be low, 10 but the prevalence of cervical dysplasias and genital warts are increasing with acceptance of more promiscuous sexual behavior. The HPV vaccine introduced in 2006 was effective in protecting against precancerous lesions of the cervix. 11 Results from randomized controlled trials (RCTs) of prophylactic HPV vaccines have shown high efficacy in preventing infection and subsequent precancerous cervical lesions associated with vaccine-type oncogenic HPV (HPV 16 and 18) as well as phylogenetically-related oncogenic HPV types. 12 Two different types of vaccines are available in Turkey, namely Gardasil (Merck and Co Inc, West point, Pa) and Cervarix (GlaxoSmithKline Biologicals, Rixensart, Belgium), but the vaccine is not in the immunization program as in many European countries and is not afforded by the government. Both of the vaccines can be obtained from the drug stores without a prescription. Bearing this knowledge in mind we designed a survey to understand the knowledge of Turkish healthcare workers and candidates (the best possible source of information for patients) about HPV, cervical cancer and HPV vaccine.
MATERIALS AND METHODS
Between December 2010 and February 2011, students of Bilim University and healthcare workers of affiliated hospitals were asked to participate in a survey to understand their knowledge about HPV, pap smear test, cervical cancer, HPV vaccine and their attitudes toward HPV vaccination. The study was designed according to the Declaration of Helsinki. A self-administered questionnaire consisting of 25-items was introduced. Students received the survey in their classroom at one time and put the completed survey in a closed box. Working staff completed the survey within 24 hours and replaced it in a closed box. The first part of the questionnaire consisted of 5 questions to determine age, sex, smoking status, contraception method and occupation in the hospital (Table 1 ). The second part of the questionnaire assessed the knowledge about smear test and HPV to give an opinion about the domains which needs awareness raising ( Table 2 ). The third part of the questionnaire included 5 questions about HPV vaccine (Table 3) . We also searched changes in responses according to history of gynecological cancer in the family (Table 4 ). The detail of situation of religious beliefs of the responders are not questioned. The study is approved by the Institutional Review Board of our University.
Statistical analysis was performed using the computer software NCSS (Number Cruncher Statistical system) 2007 & PASS 2008 statistical Software (Utah, USA). Chi-square analysis was used to compare categorical variables and p-value was calculated according to the total number of responses. A p-value< 0.05 was considered statistically significant.
RESULTS

Participants
From 743 healthcare workers and students invited, 603 of them agreed to participate in the self-administered survey and completed it. The response rate was 81.2%. A small part of the participants rejected the survey. Their mean age was 25.4±6.4 years. Participants were grouped into three: 19.1% of the participants were students of medicine (SOM) (first 3 years), 47.9% of them were nurses+students of nursing of the last year (SON), 23% of them were secretaries/technicians and other healthcare personnel (HCP). Regarding the data 20.2% of the participants were males and 79.8% were females. A large proportion of the subjects never had sexual intercourse (56.3% of women and 32.8% of men). During sexual intercourse 21.1% of the participants used condoms, 6.6% used intrauterine device, 14.9% used oral contraceptives, 1.2% used other hormonal contraceptives, 7.5% used coitus interruptus as a contraceptive method and 3.6% had tubal ligation. When we look at the smoking status, 43.4% of males and 27.4% of females were smokers (Table 1) . When they were asked about pap smear test, 77.4% of respondents correctly answered that a pap smear test is a cervical cancer screening test, 7.6% believed that it was a STD test, 1% believed that it was a cancer treatment, 10.8% had no idea. When the knowledge about pap smear frequency was searched, 70.3% of respondents answered it correctly. Only 8% knew that smear tests should continue after HPV vaccination (Table 2) .
Only women had to answer the next 3 questions, 42% had a gynecological examination before the survey, 21.6% had a smear test before the survey and 1.3% had a history of abnormal pap smear result before. Those who have had a gynecological examination before the survey correctly answered that a pap smear is a cervical cancer screening test (87.6% ), pap smears are done yearly (83.6 %), HPV is the causative agent of cervical cancer (77.6%) and HPV is transmitted sexually (81.1%), but there was no statistically significant difference between the groups.
Knowledge and attitudes about HPV vaccination
When the knowledge about HPV vaccine was searched, 15.5% of participants believed that the vaccine prevented cervical cancer totally, 43% answered that they had no idea and 16.6% believed that it prevented other STDs. Only 4% of participants were vaccinated. When the willingness to get their daughter vaccinated (a daughter or a supposed future one) was searched, 52.1% of the respondents were willing to accept it. Those who were not willing to get their daughters vaccinated reported the safety of the vaccine (41.2%) as the main reason. The price of the 3 doses of vaccine was given as US $ 275 and it was considered as an objection for vaccination by 9.7% of the participants. Only 4.5% of the respondents were concerned that vaccination would lead to more risky sexual behaviors, religion was not an obstacle. Some of the respondents accepted to get their daughters vaccinated when the government paid for it. Having a relative with a gynecological cancer did not change the acceptability of the vaccine for the daughter and it did not increase the number of women taking the vaccine (5.9% versus 3.6%, p=0.426). A previous history of a STD also did not change the acceptability of the vaccine, but the number of this group of respondents was small. Those who have had a gynecological examination previously had an increased acceptability of the vaccine for their daughters (63.7% versus 47%, p=0.001) and they were less concerned for the safety of the vaccine (11.9% versus 31.9%, p=0.01) ( 
DISCUSSION
The prevalence of HPV infection in hospital based investigations in low-risk Turkish women was reported as 2%, 10 but a hospital looking after women with a high level of education reported a prevalence of 16%, 13 in Turkey better education and income are associated with more promiscuous sexual attitudes. Cervical cancer has a long preinvasive phase, as the conservative nature of our culture changes, premarital sexual contact and polygamy becomes more common, the prevalence of HPV will certainly increase to the rates reported worldwide. 13 In this survey females had significantly more knowledge about HPV and smear test. Also SOM performed better than the other two groups when the items about HPV were considered, but SON answered the questions about smear test more correctly. This is most probably related to gender, nearly all of the SON are females in Turkey. Previously in a similar study of SOM and midwives, midwives were found to have more knowledge about HPV and HPV vaccine than SOM. 14 Main source of knowledge in our subjects was school (37%), followed by media (newspaper-television, 36%) and internet (32%), similar to the previous reports.
Vaccination prior to HPV exposure is likely to provide the greatest benefit; more than half our respondents never had sexual intercourse before. However only 4% had the vaccine, a level similar to that reported in previous studies, 15 To be sexually inactive or monogamy 16 may be the reasons for postponing of the vaccination.
We tried to estimate the intention of vaccine providers to immunization by asking whether they would get their daughters vaccinated or not, as intention has been associated with behaviors. 17 Nearly half of them rejected to vaccinate their daughters. Previously reported vaccine acceptance of Turkish women for their daughters was higher. 15, 18 Intentions from other parts of the world were also higher. 7, [19] [20] [21] The main reluctance of our respondents when deciding to vaccinate their daughters appeared to be the concerns about vaccine safety, similar to that reported from a survey in physicians 22 and university students, 9 but less than that from other studies. 8, 15, 23 Females were more concerned about vaccine safety when compared to males and nurses were more concerned when compared to the other groups. Females with a previous gynecological examination had a statistically significantly higher vaccine acceptance for their daughters and they were less concerned about the vaccine safety. Although vaccine acceptance was the highest among SOM (65%), it is still very low. Confusions about the safety of HPV vaccination should be rectified as these will be directed to the general population and will decrease the patient compliance and adherence. 24 Other obstacles were shared commonly. One of the factors that can have an impact on HPV vaccination is the vaccine cost. Nearly 10% of our respondents considered the cost of the vaccine as an important barrier to vaccination. The cost of three doses of vaccine is approximately equal to the monthly income of our HCP and is approximately half of the monthly income of a nurse. Our data provide evidence that the monthly income did not change the vaccine acceptability as was supported previously. 20 Other studies related lower income to higher vaccine acceptance 7, 25, 26 or contrarily lower income to decreased interest in vaccination. 27, 28 Nearly 15% of the respondents answered that they would vaccinate their daughters only when the government paid for it; there was a statistically significant difference between male and female respondents, females were in favor of vaccination more than males whether the government paid for it or not, probably because the cervical cancer affects females. Also HCP were more likely to accept vaccination if the government paid for it, this is most probably related to the poorer knowledge and education of this group or to the male preponderance, as males have been reported to have lower awareness of HPV and cervical cancer risk 20 or may be related to low knowledge higher vaccine acceptance. 29 An attitude as a general opposition to vaccination was rare and religion was not considered as an obstacle for HPV vaccination. Previous studies showed that a main barrier to vaccine acceptance was the concern that HPV vaccination could lead to more promiscuous sexual behavior, 30, 31, 32, 33 that was put forward by less than 5% of our respondents and was similar to that of other reports. 15, 34 The primary goal in HPV vaccination is to prevent cervical cancer, but the inclusion of HPV types associated with genital warts may increase their interest in the vaccine. 35 Only 25% of our respondents knew that HPV caused both cervical cancer and genital warts. Unfortunately 55% of the respondents had the false beliefs that the HPV vaccine would protect them against STDs other than HPV and 8% assumed that there was no need to have pap smears after HPV vaccine, similar to the findings of a previous report. 23 It is also critical to mention the false sense of security with respect to cervical cancer risk after HPV vaccination. Only 42% of the study participants knew that the protection after HPV vaccination is not complete, 84% agreed that the smear tests should be performed after vaccination. The discrepancy between the answers is probably due to attribution of other diagnostic values to smear test besides being a cervical cancer screening test.
Vaccine acceptance for daughters was statistically significantly higher among SOM (65%). This emphasizes on the need to increase awareness about cervical cancer in doctors and nurses who are involved in the primary care of the patients and an important source of guidance for them. Other healthcare workers are not directly involved in providing clinical care and health education, but they can still be a role model in the population. It is also important to assess the factors that affect vaccine decision-making in this relatively young population, half of whom had no sexual intercourse.
A previous study conducted in women treated for cervical cancer discerned very low HPV knowledge, 36 contrarily history of cervical cancer in family or friends was found to be associated with higher HPV vaccine knowledge. 8, 37, 39 Our data provides evidence that having had a family history of a gynecological cancer was not associated with higher vaccine acceptance for a daughter or vaccine knowledge.
The main reason for rejecting to complete the survey was being busy. SOM were from the first three years, they answered the survey before taking gynecology lessons, and therefore we can hope better results with the interns.
In Turkey pap smear tests are paid by the government but implementation of HPV immunization is not a policy of the near future. In countries with school-based immunization programs HPV vaccine uptake is already high (80%). 39 We hope to increase awareness about HPV, cervical cancer and HPV vaccination with better education of healthcare providers, whom can play an active role in educating and informing patients. The willingness of healthcare providers to recommend HPV vaccination may increase community demand for vaccination. It is fundamental to improve knowledge and awareness of healthcare personnel with effective education programs both in university and in professional life in a country where promiscuous sexual attitudes are rising and HPV vaccination is not in the immunization schedule.
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